On the occasion of National Bioproduction and Biomedicines Day (JNBB), which enjoys the high patronage of the President of ...

make in the product. It can be attractive to just do what the rest of the industry is doing. For instance, one study of 458 pharmaceutical and biotechnology license agreements found a 7% average ...

Image source: Getty Images. There are even different regulatory paths for biotech and pharma products in the U.S. Companies that develop therapies made from living organisms must file a Biologics ...

Pierre MORGON has over 25 years experience in the pharmaceutical ... with blockbuster products in diverse markets (primary care, specialty care, hospital, vaccines, and biotechnology), geographies ...

Trailblazing innovations in pharmaceuticals, biotechnology, medical technology, public sector, and digital health honoured at prestigious London ceremony LONDON, June 6, 2025 /PRNewswire/ ...

The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international collaboration.

Lupin and SteinCares ink license and supply agreement for ranibizumab in Latin America: Our Bureau, Mumbai Monday, May 26, 2025, 14:10 Hrs [IST] Global Pharma major Lupin Limited ...